Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LEXX

Lexaria Bioscience Corp.

CIK 0001348362 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$10.91
↓ 0.36 (-3.15%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$18.04M
P/E Ratio
-2.33
EPS
Not covered
Dividend Yield
Not covered
52W Position
84%
Beta
0.51

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
4.15
P/S
92.97
EV/Revenue
74.93
ROE
-178.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 84%
$0.35$12.89

Latest Financials

2025-08-31 FY
Revenue
$705.92K
Net Income
-$11.90M
Total Assets
$4.18M
Free Cash Flow
-$10.48M

Recent news